Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review

Acute pancreatitis can result in death or serious consequences including chronic pancreatitis, diabetes mellitus, and organ failure. Causes of acute pancreatitis include gallstones, alcohol, and severe hypertriglyceridemia (triglyceride levels ≥5.6 mmol/L [500 mg/dL]), which affects approximately 1% of the population. Hypertriglyceridemia-associated acute pancreatitis warrants special attention because of its higher mortality rate, increased incidence of pancreatic necrosis, greater need for intensive care, and longer duration of hospitalization relative to other causes; it is also likely to recur but is potentially preventable. Addressing the cause of moderate or severe hypertriglyceridemia followed by combining diet modifications, optimizing medication, and counseling on reduction/cessation of alcohol consumption, with conventional treatments (e.g., fibrates), is important to reduce triglyceride levels and acute pancreatitis incidence. Recent analyses of randomized controlled trials with approved apolipoprotein C-III-targeting drugs show that lowering triglyceride levels by ≥40% is associated with lower acute pancreatitis risk. Patients with acute pancreatitis present with intense abdominal pain, nausea, and vomiting. Diagnosis is based on symptoms, elevated serum amylase or lipase levels, and/or radiographic evidence. Etiology is determined using personal/family history, physical examination, and laboratory tests; past triglyceride measurements can be helpful, as patients may be fasted and present with lower triglyceride levels. Treatment is primarily supportive to allow pancreatic rest and manage hypertriglyceridemia, with monitoring for complications. Recognition of severe hypertriglyceridemia as an important cause of severe acute pancreatitis is critical for its prevention and management. Consulting specialists with expertise in the treatment of severe hypertriglyceridemia is key to managing complications and preventing recurrence.

Authors

Institutions

Publication Details

Journal
European Journal of Internal Medicine
Published
2025-12-23
DOI
https://doi.org/10.1016/j.ejim.2025.106648
Citations
2
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
4.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review

Asia Sikora Kessler, Monica R. McClain, Handrean Soran, Robert H. Eckel et al.
2 citations
European Journal of Internal Medicine
Pancreatitis Pathology and Treatment
4.01
article

Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review

Asia Sikora Kessler, Monica R. McClain, Handrean Soran, Robert H. Eckel, Robert S. Rosenson, Savitha Subramanian
article en
2 citations

Abstract

Acute pancreatitis can result in death or serious consequences including chronic pancreatitis, diabetes mellitus, and organ failure. Causes of acute pancreatitis include gallstones, alcohol, and severe hypertriglyceridemia (triglyceride levels ≥5.6 mmol/L [500 mg/dL]), which affects approximately 1% of the population. Hypertriglyceridemia-associated acute pancreatitis warrants special attention because of its higher mortality rate, increased incidence of pancreatic necrosis, greater need for intensive care, and longer duration of hospitalization relative to other causes; it is also likely to recur but is potentially preventable. Addressing the cause of moderate or severe hypertriglyceridemia followed by combining diet modifications, optimizing medication, and counseling on reduction/cessation of alcohol consumption, with conventional treatments (e.g., fibrates), is important to reduce triglyceride levels and acute pancreatitis incidence. Recent analyses of randomized controlled trials with approved apolipoprotein C-III-targeting drugs show that lowering triglyceride levels by ≥40% is associated with lower acute pancreatitis risk. Patients with acute pancreatitis present with intense abdominal pain, nausea, and vomiting. Diagnosis is based on symptoms, elevated serum amylase or lipase levels, and/or radiographic evidence. Etiology is determined using personal/family history, physical examination, and laboratory tests; past triglyceride measurements can be helpful, as patients may be fasted and present with lower triglyceride levels. Treatment is primarily supportive to allow pancreatic rest and manage hypertriglyceridemia, with monitoring for complications. Recognition of severe hypertriglyceridemia as an important cause of severe acute pancreatitis is critical for its prevention and management. Consulting specialists with expertise in the treatment of severe hypertriglyceridemia is key to managing complications and preventing recurrence.

European Journal of Internal MedicineVol. 145
University of Washington (US), Ionis Pharmaceuticals (United States) (US), Mount Sinai Hospital (US), Mount Sinai Hospital (US), NIHR Wellcome Trust Southampton Clinical Research Facility (GB), University of Colorado Anschutz Medical Campus (US)
Ionis Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 5%
Pancreatitis Pathology and Treatment
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.